HomeNewsBusinessReal EstateDemand for plots and independent floors stages strong comeback in pandemic, overtakes apartments

Demand for plots and independent floors stages strong comeback in pandemic, overtakes apartments

Gurugram, Hyderabad, Bengaluru, Chennai record double-digit growth in prices for residential plots

January 12, 2022 / 12:34 IST
Story continues below Advertisement

The demand for plots and independent floors has staged a strong comeback during the pandemic outstripping apartments. 

Prices of residential plots have clocked a compound annual growth rate (CAGR) of 7 per cent since 2015 across eight major cities, while rates of apartments grew 2 per cent (CAGR) during the period, research by the REA India, which owns full stack digital real estate platform Housing.com, showed.

Story continues below Advertisement

"Residential plots have been able to generate higher returns on investment. One of the reasons could be the limited supply of plots in big cities because of a paucity of large land parcels," said Dhruv Agarwala, CEO, Housing.com, Makaan.com and PropTiger.com.

"The demand for plots and independent floors has come back. Developers are trying to meet this rise in demand by launching such projects on the outskirts of big cities," Agarwala said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show